Trial · NCT04581863
Outcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Difference in Days Alive and Out of Hospital | 30 days | days | MEAN | |
| OTHER_PRE_SPECIFIED | Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | Days | MEAN | |
| OTHER_PRE_SPECIFIED | Self-reported Anxiety Among COVID-19 Positive Patients | 0, 7, and 14 days | score on a scale | MEAN | |
| OTHER_PRE_SPECIFIED | Self-perception of Confidence in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | score on a scale | MEAN | |
| OTHER_PRE_SPECIFIED | Self-perception of Program Helpfulness in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | score on a scale | MEAN | |
| OTHER_PRE_SPECIFIED | Mortality Among COVID-19 Positive Patients | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Mortality by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) | 30 days | Number of Visits/Hospitalizations | MEAN | |
| OTHER_PRE_SPECIFIED | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | Number of Visits/Hospitalizations | MEAN | |
| OTHER_PRE_SPECIFIED | Incidence of Remote Monitoring Escalations to Clinician | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Timing of Remote Monitoring Escalations to Clinician | 30 days | minutes | MEAN | |
| OTHER_PRE_SPECIFIED | Self-Reported Symptom Self-Management Among COVID-19 Positive Patients | 30 days | A single participant could be escalated multiple times. | Escalations | COUNT_OF_UNITS |
| OTHER_PRE_SPECIFIED | Days Between Program Enrollment and Home Pulse Oximetry Initiation | 30 days | The control arm was not given pulse oximeters for SpO2 to be measured as per study design. | Days | MEAN |
| OTHER_PRE_SPECIFIED | Timing of Initial Presentation of Covid-19 Positive Patients Who Returned to Emergency Department | 30 days | Days | MEAN | |
| OTHER_PRE_SPECIFIED | Severity of Initial Presentation of Covid-19 Positive Patients Who Returned to Emergency Department as Measured by Oxygen Saturation | 30 days | Oxygen Saturation (%) | MEAN | |
| OTHER_PRE_SPECIFIED | Incidence of Subsequent Emergency Department Referrals | 30 days | referrals | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04581863/outcomes